Showing results (21-30 of 94) with videos related to

Sort By:
Pageof 10
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|January 12, 2023
Panoramic ultrasound imaging does not produce muscle morphology deformation during imaging acquisition: A validity studyJuan Antonio Valera-Calero, Gustavo Plaza-Manzano, Ricardo Ortega-Santiago, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 13, 2014
First-line mono-chemotherapy in frail elderly patients with metastatic colorectal cancerUmut Varol, Ahmet Dirican, Ibrahim Yildiz, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 5, 2019
Prevalence and related factors of sarcopenia in newly diagnosed cancer patientsUtku Oflazoglu, Ahmet Alacacioglu, Umut Varol, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|December 24, 2014
Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell linesAhmed Dirican, Cigdem Erten, Harika Atmaca, et al.
Sensors (Basel, Switzerland)|February 11, 2023
Inter-Examiner Disagreement for Assessing Cervical Multifidus Ultrasound Metrics Is Associated with Body Composition FeaturesUmut Varol, Marcos José Navarro-Santana, Sonia Gómez-Sánchez, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 24, 2019
Chemotherapy-induced sarcopenia in newly diagnosed cancer patients: Izmir Oncology Group (IZOG) studyUtku Oflazoglu, Ahmet Alacacioglu, Umut Varol, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 9, 2014
Zoledronic acid increases cytotoxicity by inducing apoptosis in hormone and docetaxel-resistant prostate cancer cell linesUmut Varol, Mustafa Degirmenci, Burcak Karaca, et al.
Molecular and Clinical Oncology|March 21, 2014
Tumor characteristics and metastatic sites may predict bevacizumab efficacy in the first-line treatment of metastatic colorectal cancerUmut Varol, Esin Oktay, Mustafa Yildirim, et al.
Pageof 10